Ikarian Capital, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value (AVTX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol: AVTX
Shares outstanding: 18,735,974 shares
Disclosed Ownership: 711,967 shares
Ownership: 3.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 18:26:50 UTC
Date of event: 30 Sep 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	3.8%	711,967	0	711,967	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	3.8%	711,967	0	711,967	/s/ Neil Shahrestani	Neil Shahrestani